Health Economics Review

Papers
(The TQCC of Health Economics Review is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The healthcare costs of increased body mass index–evidence from The Trøndelag Health Study103
Contracting with sequential care providers56
The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy52
Building an integrated healthcare system of China: an assessment of coupling coordination between disease prevention, medical services, and healthcare financing from 2012 to 202145
A cost-effectiveness analysis comparing single-inhaler extrafine beclomethasone/formoterol/glycopyrronium bromide against other SITTs in adult patients with uncontrolled asthma in England43
End-of-life expenditure on health care for the older population: a scoping review30
Evaluating a capacity development intervention in health economics among producers and users of evidence in Nigeria: a case study in Getting Research Into Policy and Practice (GRIPP) in Anambra State29
Governance and public health expenditure in Côte d'Ivoire: examination of the dynamic relationship28
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea27
Valuation of informal care for the old-aged with disabilities in China—a discrete choice experiment approach25
Utilization of maternal health facilities and rural women’s well-being: towards the attainment of sustainable development goals23
Evaluating the costs of adverse drug events in hospitalized patients: a systematic review22
Impact of diabetes diagnosis on dental care utilization: evidence from Finland21
Adjuvant treatment of high-risk melanoma – cost-effectiveness analysis of treatment options for BRAF 600 mutated tumors21
Health insurance coverage in Ethiopia: financial protection in the Era of sustainable development goals (SDGs)20
Correction: Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan18
Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran17
Policies and cost analyses of voluntary assisted dying (VAD) laws – a mapping review & analysis17
Support by telestroke networks is associated with increased intravenous thrombolysis and reduced hospital transfers: A german claims data analysis17
Estimating the budget impact of a Tuberculosis strategic purchasing pilot study in Medan, Indonesia (2018–2019)17
The economic impact of anastomotic leak after colorectal cancer surgery17
Cost-effectiveness analysis of combination therapies involving novel agents for first/second-relapse patients with multiple myeloma: a Markov model approach with calibration techniques16
Kidney transplant cases in US: study of determinants of variance in hospital charges and inpatient care16
A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition16
The cost of readmissions in hospitals: the case of the Spanish public hospitals15
Catastrophic health expenditures: a disproportionate risk in uninsured ethnic minorities with diabetes15
Sustaining medical research – the role of trust and control15
An equity analysis on the household costs of accessing and utilising maternal and child health care services in Tanzania14
Robot-assisted approach versus open surgery and conventional laparoscopy for radical prostatectomy for prostate cancer: a micro-costing study13
Endogenous health risks, poverty traps, and the roles of health insurance in poverty alleviation13
The economic costs of orthopaedic services: a health system cost analysis of tertiary hospitals in a low-income country13
Health system efficiency in OECD countries: dynamic network DEA approach13
Cost effectiveness of imaging strategies in the emergency department for the diagnostic workup of community-acquired pneumonia: a real-life retrospective study13
The temporal and spatial interpretation of China’s health financing: what do Chinese’ government ‘do’ in new healthcare reform?12
Rehabilitation in the long-term care insurance domain: a scoping review12
Historical origins of corruption in the Romanian public health system - path dependency and contagion effect12
A scoping review of COVID-19 economic response policies in the MENA countries: lessons learned for Iran for future pandemics12
Health economic evaluation of an electronic mindfulness-based intervention (eMBI) to improve maternal mental health during pregnancy – a randomized controlled trial (RCT)12
Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting11
NHS reference costs: a history and cautionary note11
Research trends in contemporary health economics: a scientometric analysis on collective content of specialty journals11
Does targeted information impact consumers’ preferences for value-based health insurance? Evidence from a survey experiment10
The impact of hospital price and quality transparency tools on healthcare spending: a systematic review10
Cost-effectiveness analysis of parenteral iron therapy compared to oral iron supplements in managing iron deficiency anemia among pregnant women10
Correction: Direct and indirect savings from parallel imports in Sweden10
Difference in time and risk preferences: physicians and general population across genders9
Fragmentation of payment systems: an in-depth qualitative study of stakeholders’ experiences with the neonatal intensive care payment system in Iran9
Impact of Tobacco Use and Prevention Laws on Regional Cigarette Sales: An Analysis of Provincial Disparities and Convergence Patterns in Spain9
Measuring productivity in the healthcare sector: a bibliometric and content analysis9
The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data9
The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China9
Cost-utility analysis of Palbociclib + letrozole and ribociclib + letrozole versus Letrozole monotherapy in the first-line treatment of metastatic breast cancer in Iran using partitioned survival mode8
Quality of public health insurance and individuals’ consumption structure upgrades: evidence from China8
The economic effect of financial compensation in China’s healthcare system: comprehensive insights regarding supply and demand factors8
A comparison of measurement properties between EORTC QLU-C10D and FACT-8D in patients with hematological malignances8
Cost of peer mystery shopping to increase cultural competency in community clinics offering HIV/STI testing to young men who have sex with men: results from the get connected trial8
The heterogeneous association between education and the adoption of safe food handling practices in Ethiopia8
Correction: Cost-effectiveness analysis of sintilimab plus pemetrexed and platinum versus chemotherapy alone as first-line treatment in metastatic non-squamous non–small cell lung cancer in China7
The level of countries’ preparedness to health risks during Covid-19 and pre-pandemic: the differential response to health systems building blocks and socioeconomic indicators7
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan7
Diabetes diagnosis based on glucose control levels and time until diagnosis: a regression discontinuity approach to assess the effect on direct healthcare costs7
Supply-side factors influencing demand for facility-based delivery in Tanzania: a multilevel analysis7
Health economic evaluations of diagnostic tests for tuberculosis: a narrative review7
A Hierarchical Bayesian approach to small area estimation of health insurance coverage in Ethiopian administrative zones for better policies and programs7
A decade of liver transplantation in Mongolia: Economic insights and cost analysis7
Effect of COVID-19 on demand for healthcare in Togo7
Correction: A comparative study of bibliometric analysis on old adults’ cognitive impairment based on web of science and CNKI via CiteSpace7
Knowledge domain and emerging trends in multimorbidity and frailty research from 2003 to 2023: a scientometric study using citespace and VOSviewer6
Framing financial incentives to promote hypertension care among rural primary doctors in Shandong Province, China: study protocol of a randomized field trial6
How much do government and households spend on an episode of hospitalisation in India? A comparison for public and private hospitals in Chhattisgarh state6
Should we adjust health expenditure for age structure on health systems efficiency? A worldwide analysis6
Economic impact of powered stapler in video-assisted thoracic surgery lobectomy for lung Cancer in a Chinese tertiary hospital: a cost-minimization analysis6
Health shocks and households’ vulnerability to poverty in Nigeria: a quasi-experimental analysis6
Systematic review of the economic evaluation model of assisted reproductive technology6
Forecasting emergency department arrivals using INGARCH models6
Impact of reimbursement systems on patient care – a systematic review of systematic reviews6
What can we learn about the impact of cancelled planned operations on waiting times? A case study using the 2017/18 winter flu postponement policy in England6
How innovation can be defined, evaluated and rewarded in health technology assessment6
Estimating the cost for obstetric fistula repair in hospitals of Mozambique: a low-income country6
The role of Iran's context for the development of health technology assessment: challenges and solutions6
Does poverty increase COVID-19 in Africa? A cross-country analysis6
AI integration in energy management: enhancing efficiency in Italian hospitals6
0.041517019271851